scispace - formally typeset
P

Paul Hewitson

Researcher at University of Oxford

Publications -  33
Citations -  3274

Paul Hewitson is an academic researcher from University of Oxford. The author has contributed to research in topics: Colonoscopy & Colorectal cancer. The author has an hindex of 19, co-authored 33 publications receiving 3017 citations.

Papers
More filters
Journal ArticleDOI

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

TL;DR: This review confirms previous research demonstrating that FOBT screening reduces the risk of CRC mortality and indicates that there is no difference in all-cause mortality between the screened and nonscreened populations.
Journal ArticleDOI

Screening for colorectal cancer using the faecal occult blood test, hemoccult.

TL;DR: Whether screening for colorectal cancer using the faecal occult blood test (guaiac or immunochemical) reduces coloreCTal cancer mortality and to consider the benefits, harms and potential consequences of screening is reviewed.
Journal ArticleDOI

European guidelines for quality assurance in colorectal cancer screening and diagnosis : Overview and introduction to the full Supplement publication.

L. von Karsa, +113 more
- 01 Jan 2013 - 
TL;DR: An overview of the principles, recommendations and standards in the guidelines for quality assurance in CRC screening and diagnosis are presented in journal format in an open-access Supplement of Endoscopy.
Journal ArticleDOI

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Communication

TL;DR: The content of the chapter is presented here to promote international discussion and collaboration by making the principles and standards recommended in the new EU Guidelines known to a wider professional and scientific community.
Journal ArticleDOI

Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.

TL;DR: Including both an endorsement letter from each patient's GP and a more explicit procedural leaflet could increase participation in the English Bowel Cancer Screening Programme by ∼10%, a relative improvement of 20% on current performance.